Development and Validation of a Simplified Financial Toxicity Screening Tool for Use in Clinical Practice.

ABSTRACT:

Purpose

Cancer-related financial toxicity occurs frequently and is a key driver of inequities in access to care and disparities in treatment outcomes. Current practices to screen for financial toxicity are inconsistent because of the lack of a validated and clinically integrated screening tool. This analysis aimed to create and assess an abbreviated version of the validated Comprehensive Score for Financial Toxicity (COST) tool, a measure of financial toxicity used for research purposes, which could easily be added into often-lengthy clinical screening workflows.

Methods

At an urban comprehensive cancer center with suburban satellite locations, a financial toxicity screening quality improvement project was conducted from June 2022 to August 2023 as part of routine clinical c

SUBMITTER: Thom B 

PROVIDER: S-EPMC12305446 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature